Congenica
Cambridge
About Congenica
Congenica is a biotechnology company that provides a diagnostic decision support platform. They have translated this research into the gold standard clinical genomic analytics platform, Sapientia, providing integration of human DNA sequences with deep clinical phenotyping, enabling clinicians to provide an actionable interpretation of genetic disease for patients. It was founded in 2013 and headquartered in Cambridge, Cambridgeshire.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Estimated revenue: $1K – $10K
- Total funding: $82.4M
- Funding stage: M&A
- Last round: Series C (Mar 2021)
- Website: congenica.com
- Phone: +44-1223-499-965
Industries & Categories
Bioinformatics, Biotechnology, Genetics, Health Care, Medical
Social Profiles
Canonical: https://fsome.com/organization/congenica-39290 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.